http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Agilent Early Career Professor Award Presented to Jason H. Yang
-
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
-
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
-
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
-
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
-
Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
-
MOBILion Systems Inc. Announces $60 Million Series C Financing Round Led by D1
-
Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
-
Agilent Completes the InfinityLab Bio LC Portfolio
-
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
-
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
-
Agilent Announces New SureSelect Human All Exon V8
-
Agilent Presents Thought Leader Award to Professor Chris Elliott
-
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results
-
Agilent to Present at Jefferies Virtual Healthcare Conference
-
Agilent Announces Cash Dividend of 19.4 Cents per Share
-
Agilent to Webcast Second-Quarter Fiscal Year 2021 Financial Results Presentation
-
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
-
Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology
-
Agilent Named One of Singapore’s Best Employers
-
Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use
-
Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
-
Agilent Announces Cash Dividend of 19.4 Cents per Share
-
Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence
-
Agilent Technologies (A) Announces Dr. Katharine Knobil Named First Chief Medical Officer
-
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
-
Agilent Technologies (A) Confirms Deal to Acquire Resolution Bioscience
-
Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
-
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
-
Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
-
Agilent Technologies (A) Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
-
Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
-
Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
-
Agilent Reports First-Quarter Fiscal Year 2021 Financial Results
-
Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
-
Agilent Wins Trade Secret and Patent Infringement Litigation
-
Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
-
Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines
-
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
-
Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
-
Agilent Announces Webcasts for Investment Community
-
Agilent Receives Multiple Innovation Awards
-
Agilent Releases 2019 Corporate Social Responsibility Report
-
Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
-
Agilent Announces Alissa Interpret Selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
-
Agilent Announces New, Innovative 7850 ICP-MS System
-
Agilent Announces Launch of Global Biomarker Pathologist Training Program
-
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
-
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
-
Agilent Increases Cash Dividend to 19.4 Cents Per Share

